Clinical Trial: Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis

U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07694466) titled 'Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis' on June 22.

Brief Summary: This outpatient study examines how inhaled cannabis, combustible or vaporized, alters lung health and breath biomarkers compared to a tobacco cigarette.

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Cannabis Use Tobacco Biomarkers

Intervention: DRUG: Cannabis (THC)

Active Cannabis (THC) will be inhaled.

DRUG: Tobacco Cigarette

A leading brand of tobacco cigarette (~1.0 gram; Marlboro Gold; Phillip Morris International)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Hannah Harris

Information provided by (Re...